|
STOCKHOLDERS' EQUITY (Details Textual) (USD $)
|
1 Months Ended | 3 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | 4 Months Ended | 12 Months Ended | 4 Months Ended | 12 Months Ended | 4 Months Ended | 12 Months Ended | 4 Months Ended | 12 Months Ended | 4 Months Ended | 12 Months Ended | 12 Months Ended | 4 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 31, 2010
|
Mar. 31, 2011
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2006
|
Apr. 02, 2012
|
Mar. 22, 2012
|
Feb. 29, 2012
|
Feb. 13, 2012
|
Jul. 31, 2011
|
Jun. 03, 2011
|
Apr. 30, 2011
|
Apr. 15, 2011
|
Sep. 30, 2010
|
Jun. 03, 2010
|
Aug. 03, 2006
|
Sep. 30, 2012
Plan 2012 [Member]
|
Sep. 30, 2012
Plan 2006 [Member]
|
Sep. 30, 2012
Secured Convertible Subordinated Notes Payable [Member]
|
Jul. 31, 2011
Secured Convertible Subordinated Notes Payable [Member]
|
Sep. 30, 2012
Unsecured Convertible Notes Payable [Member]
|
Feb. 29, 2012
Unsecured Convertible Notes Payable [Member]
|
Sep. 30, 2012
Warrant One [Member]
|
Sep. 30, 2011
Warrant One [Member]
|
Dec. 31, 2011
Warrant One [Member]
|
Sep. 30, 2012
Warrant One [Member]
Unsecured Convertible Notes Payable [Member]
|
Sep. 30, 2012
Warrant Two [Member]
|
Sep. 30, 2011
Warrant Two [Member]
|
Sep. 30, 2012
Warrant Three [Member]
|
Sep. 30, 2011
Warrant Three [Member]
|
Sep. 30, 2012
Warrant Four [Member]
|
Sep. 30, 2011
Warrant Four [Member]
|
Dec. 31, 2011
Warrant Four [Member]
|
Sep. 30, 2012
Common Stock [Member]
|
Sep. 30, 2011
Common Stock [Member]
|
Sep. 30, 2012
Minimum [Member]
|
Dec. 31, 2011
Minimum [Member]
Warrant One [Member]
|
Sep. 30, 2012
Maximum [Member]
|
Dec. 31, 2011
Maximum [Member]
Warrant One [Member]
|
Sep. 30, 2011
Consultants [Member]
|
Apr. 30, 2011
Sail Venture Partners [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Apr. 30, 2011
Co Investment Partners L P [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Sep. 30, 2012
Meyer Proler Md [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Apr. 30, 2011
Meyer Proler Md [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Apr. 30, 2011
Highland Longshort Healthcare Fund [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Sep. 30, 2012
Cummings Bay Capital Lp [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Apr. 30, 2011
Cummings Bay Capital Lp [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Apr. 30, 2011
Immediate Family Member Of Management Or Principal Owner [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Sep. 30, 2012
Investor [Member]
Warrant Three [Member]
|
Dec. 31, 2011
Investor [Member]
Warrant Three [Member]
|
Apr. 30, 2011
Investor [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Sep. 30, 2012
Andy Sassine [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Apr. 30, 2011
Andy Sassine [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Sep. 30, 2012
Investor One [Member]
Warrant One [Member]
|
Sep. 30, 2012
Investor Two [Member]
Warrant One [Member]
|
Sep. 30, 2012
Investor Two [Member]
Warrant Two [Member]
|
Dec. 31, 2011
Director [Member]
Warrant One [Member]
|
Mar. 22, 2012
Director One [Member]
|
Mar. 22, 2012
Director Two [Member]
|
Apr. 30, 2011
Chief Financial Officer [Member]
Warrant Three [Member]
Secured Convertible Subordinated Notes Payable [Member]
|
Sep. 30, 2012
C N S California [Member]
|
Sep. 30, 2012
Colorado C N S Response [Member]
|
Sep. 30, 2012
Neuro-Therapy Clinic Inc [Member]
|
Sep. 30, 2012
Affiliated Entity [Member]
Warrant One [Member]
|
Sep. 30, 2012
Affiliated Entity [Member]
Warrant One [Member]
Unsecured Convertible Notes Payable [Member]
|
Dec. 31, 2011
Affiliated Entity [Member]
Warrant Three [Member]
|
|||||
| Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 | 80,000,000 | 1,000,000 | 10,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock, shares issued (in shares) | 1,914,175 | 1,871,352 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock, shares outstanding (in shares) | 1,914,175 | 1,871,352 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock, Shares Authorized | 20,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock issued for consulting services paid in-lieu of cash (in shares) | 3,123 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued for accounts payable | $ 44,000 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock, Capital Shares Reserved for Future Issuance | 666,667 | 750,000 | 333,334 | 333,334 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee | 133,333 | 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms | The option price for each share of stock subject to an option shall be (i) no less than the fair market value of a share of stock on the date the option is granted, if the option is an ISO, or (ii) no less than 85% of the fair market value of the stock on the date the option is granted, if the option is a NSO; provided, however, if the option is an ISO granted to an eligible employee who is a 10% shareholder, the option price for each share of stock subject to such ISO shall be no less than 110% of the fair market value of a share of stock on the date such ISO is granted. Stock options have a maximum term of ten years from the date of grant, except for ISOs granted to an eligible employee who is a 10% shareholder, in which case the maximum term is five years from the date of grant. ISOs may be granted only to eligible employees. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Conversion, Converted Instrument, Warrants or Options Issued | 1,684,515 | 446,675 | 30,000 | 613,782 | 111,100 | 31,112 | 5,558 | 696,673 | 138,897 | 5,334 | 10,002 | 31,251 | 24,307 | 8,334 | 5,556 | 22,223 | 25,000 | 8,334 | 2,778 | 26,667 | 30,558 | 33,334 | 11,112 | 60,001 | 233,335 | 250,002 | 2,778 | 13,334 | 83,334 | |||||||||||||||||||||||||||||||||||||||||
| Debt Instrument, Convertible, Conversion Price | $ 3 | $ 5,000 | $ 15 | $ 3 | $ 3 | $ 3 | $ 0.04718 | $ 3 | $ 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options | 1,999,900 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Notes Payable, Related Parties | 920,000 | 2,222,220 | 90,000 | 80,000 | 650,000 | 80,000 | 562,500 | 437,500 | 100,000 | 400,000 | 150,000 | 50,000 | 80,000 | 550,000 | 550,000 | 180,000 | 700,000 | 50,000 | 40,000 | 90,000 | 250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 305,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares, Granted | 288,334 | 15,834 | 42,670 | 15,834 | 439,689 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value | $ 14.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | 42,670 | 439,689 | 8,334 | 8,334 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Exercise Price | $ 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares, Exercised | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Number of Shares, Outstanding at December 31, 2011 | 546,746 | 524,201 | 522,396 | 504,076 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 6,132 | 6,132 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit | $ 3.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit | $ 36.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period, Shares Warrants Surrendered In Lieu Of Cash | 539 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants Outstanding Exercise Price | $ 3 | $ 9.90 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants Outstanding Weighted Average Exercise Price | $ 4.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Weighted Average Exercise Price, Granted | $ 16.50 | $ 3 | $ 14.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 290,664 | 85,634 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | 42,670 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of promissory note | 1,900 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of promissory note (in shares) | 40,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Conversion, Original Debt, Amount | 2,000,000 | 50,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Instrument, Face Amount | $ 90,000 | [1] | $ 90,000 | $ 650,000 | $ 5,000,000 | $ 150,000 | $ 250,000 | $ 2,500,000 | $ 5,000,000 | $ 90,000 | [1] | $ 90,000 | $ 2,000,000 | $ 2,500,000 | $ 750,000 | $ 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||